← Product Code [KOD](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KOD) · K033719 # BARD TIGERTAIL URETERAL CATHETER (K033719) _C.R. Bard, Inc. · KOD · Feb 4, 2004 · Gastroenterology, Urology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KOD/K033719 ## Device Facts - **Applicant:** C.R. Bard, Inc. - **Product Code:** [KOD](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KOD.md) - **Decision Date:** Feb 4, 2004 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 876.5130 - **Device Class:** Class 2 - **Review Panel:** Gastroenterology, Urology ## Indications for Use The Bard® TigerTail™ Ureteral Catheter is intended to facilitate drainage and retrograde pyelogram of the upper urinary tract. This catheter will allow access to and navigation of a torturous ureter using standard endoscopic techniques. ## Device Story Bard® TigerTail™ Ureteral Catheter; single lumen catheter with shaft and flexible tip; available in 4, 5, and 6 Fr. sizes; optional side holes. Used by physicians in clinical/endoscopic settings to facilitate upper urinary tract drainage and retrograde pyelogram. Enables navigation of tortuous ureters via standard endoscopic techniques. Device provides mechanical access to the urinary tract; aids in diagnostic imaging and fluid management. ## Clinical Evidence Bench testing only; no clinical data provided. ## Technological Characteristics Constructed of polyurethane; single lumen design with flexible tip; available in 4, 5, and 6 Fr. sizes; optional side holes. ## Regulatory Identification A urological catheter and accessories is a flexible tubular device that is inserted through the urethra and used to pass fluids to or from the urinary tract. This generic type of device includes radiopaque urological catheters, ureteral catheters, urethral catheters, coudé catheters, balloon retention type catheters, straight catheters, upper urinary tract catheters, double lumen female urethrographic catheters, disposable ureteral catheters, male urethrographic catheters, and urological catheter accessories including ureteral catheter stylets, ureteral catheter adapters, ureteral catheter holders, ureteral catheter stylets, ureteral catheterization trays, and the gastro-urological irrigation tray (for urological use). ## Predicate Devices - Bard® TigerTail™ Ureteral Catheter ([K033719](/device/K033719.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/2 description: The image shows a handwritten document with the text "K033719" at the top. Below this, the text "page 1 of 2" is written in cursive. The handwriting appears somewhat rough, and the image quality is slightly grainy. BARD # 510 (k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990. #### SUBMITTER INFORMATION: A. | Submitter's Name: | C. R. Bard, Inc., Urological Division | |------------------------------------|----------------------------------------------| | Address: | 8195 Industrial Blvd.
Covington, GA 30014 | | Contact Person: | Frances E. Harrison, RAC | | Contact Person's Telephone Number: | 770-784-6257 | | Contact Person's Fax: | 770-784-6419 | | Date of Preparation: | November 13, 2003 | #### B. DEVICE NAME: | Trade Name: | Bard® TigerTail™ Ureteral Catheter | |----------------------|-------------------------------------| | Common / Usual Name: | Ureteral Catheter | | Classification Name: | Ureteral Catheter (21 CFR 876 5130) | #### PREDICATE DEVICE NAME: C. Bard® TigerTail™ Ureteral Catheter Trade Name: #### Device Description: D. The Bard® TigerTail™ Ureteral Catheter is a single lumen catheter comprised of a shaft and flexible tip. The device is offered with or without side holes and both configurations are available in 4,5 and 6 Fr. sizes. #### Intended Use: E. The Bard® TigerTail™ Ureteral Catheter is intended to facilitate drainage and retrograde pyelogram of the upper urinary tract. This catheter will allow access to and navigation of a torturous ureter using standard endoscopic techniques. {1}------------------------------------------------ K033719 Page 2 of 2 ### Technological Characteristics Summary: F. The Bard® TigerTail™ Ureteral Catheter is constructed of polyurethane. It has the same intended use, general design and is manufactured from the same biocompatible materials as the predicate devices. ### Performance Data Summary: G. The Bard® TigerTail™ Ureteral Catheter is constructed with biocompatible materials and has been tested for performance and found equivalent to the predicate device. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle with three wavy lines representing its wings. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 FEB - 4 2004 Frances E. Harrison, RAC Director, Regulatory Affairs C. R. Bard, Inc. 8195 Industrial Blvd. COVINGTON GA 30014 Re: K033719 Trade/Device Name: Bard® TigerTail™ Ureteral Catheter Regulation Number: 21 CFR §876.5130 Regulation Name: Urological catheter and accessories Regulatory Class: II Product Code: 78 KOD Dated: November 13, 2003 Received: November 26, 2003 Dear Ms. Harrison: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adultcration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of the letter: | 8xx.1xxx | (301) 594-4591 | |----------------------------------|----------------| | 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 | | 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 | | 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 | | Other | (301) 594-4692 | Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html. Sincerely yours, Nancy C. Brogdon Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Finclosure {4}------------------------------------------------ ## INDICATIONS FOR USE STATEMENT (033719 510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________ Device Name: _________________________________________________________________________________________________________________________________________________________________ Indications for Use: The Bard® TigerTail™ Ureteral Catheter is intended to facilitate drainage and retrograde pyclogram of the upper urinary tract. This catheter will allow access to and navigation of a torturous ureter using standard endoscopic techniques. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) ## CONCURRENCE OF CDRH, OFFICE OF DEVICE EVALUATION (ODE) | Prescription Use
(Per 21 CFR 801.109) | OR | Over-The-Counter Use | |------------------------------------------|----|----------------------| |------------------------------------------|----|----------------------| (Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices | 510(k) Number | K033719 | (Optional Format 1/2/96) | |---------------|---------|--------------------------| |---------------|---------|--------------------------| --- **Source:** [https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KOD/K033719](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KOD/K033719) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com